News

VAX100 is a BCR-ABL peptide vaccine designed to reduce persistent disease in patients with chronic myeloid leukemia (CML) who have had stable disease during conventional therapy. The study

Chronic hepatitis C virus (HCV) was seen in the Japanese population decades before the US, with the result that HCV patients in Japan are 10 to 15 years

This investigation is the first to indicate that the drug trastuzumab (marketed by Genentech as Herceptin) may work better when it is followed by injections of interleukin (IL)

The license is a result of an ongoing collaborative research effort between the two companies to create novel folate conjugates of Bristol-Myers Squibb’s proprietary epothilone compounds. The conjugates

RheoGene has developed technology to manage gene expression, a key component of gene-based therapies. RheoGene’s therapeutic system uses a patented small-molecule mediator that can turn genes ‘on’ or

Cethromycin will be evaluated using a 300mg once-daily dosing regimen over a seven-day course of therapy. The clinical cure rate at the ‘test-of-cure’ visit will be the primary

Under the terms of the agreement, Prism will pay Commonwealth Biotechnologies (CBI) a nominal signing fee, milestone payments against product approvals, and royalties from net product sales. Milestone

For many patients suffering from depressive illnesses the best pharmacological treatments are those that increase levels of serotonin, the brain chemical that regulates mood, sleep and memory. New

Developed in the 1960s at Wistar, the rubella vaccine has eradicated the disease in the US, according to the US Centers for Disease Control and Prevention. Due to